Targeted molecular therapies represent a groundbreaking advancement in cancer treatment, focusing on the intricate connections between genetic mutations and protein interactions.By developing small molecules that can specifically bind to proteins involved in cancerous processes, researchers aim to disrupt the uncontrolled growth of tumors.